EGFR and lung cancer: Thus, paclitaxel-resistant lung cancers are more sensitive to gefitinib and readily undergo apoptotic cell death compared with non-resistant lung cancer, through downregulation of ABCB1, ABCC9, ABCG2, PLK1, and EGFR.